GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Scivision Biotech Inc (TPE:1786) » Definitions » Cyclically Adjusted Book per Share

Scivision Biotech (TPE:1786) Cyclically Adjusted Book per Share : NT$23.24 (As of Mar. 2025)


View and export this data going back to 2010. Start your Free Trial

What is Scivision Biotech Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Scivision Biotech's adjusted book value per share for the three months ended in Mar. 2025 was NT$24.159. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is NT$23.24 for the trailing ten years ended in Mar. 2025.

During the past 12 months, Scivision Biotech's average Cyclically Adjusted Book Growth Rate was 3.40% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 7.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Scivision Biotech was 11.90% per year. The lowest was 7.90% per year. And the median was 9.90% per year.

As of today (2025-05-30), Scivision Biotech's current stock price is NT$96.20. Scivision Biotech's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 was NT$23.24. Scivision Biotech's Cyclically Adjusted PB Ratio of today is 4.14.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Scivision Biotech was 6.02. The lowest was 2.02. And the median was 3.40.


Scivision Biotech Cyclically Adjusted Book per Share Historical Data

The historical data trend for Scivision Biotech's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Scivision Biotech Cyclically Adjusted Book per Share Chart

Scivision Biotech Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 15.78 18.23 20.43 22.09 22.92

Scivision Biotech Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 22.48 22.66 22.83 22.92 23.24

Competitive Comparison of Scivision Biotech's Cyclically Adjusted Book per Share

For the Medical Instruments & Supplies subindustry, Scivision Biotech's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Scivision Biotech's Cyclically Adjusted PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Scivision Biotech's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Scivision Biotech's Cyclically Adjusted PB Ratio falls into.


;
;

Scivision Biotech Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Scivision Biotech's adjusted Book Value per Share data for the three months ended in Mar. 2025 was:

Adj_Book= Book Value per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=24.159/134.9266*134.9266
=24.159

Current CPI (Mar. 2025) = 134.9266.

Scivision Biotech Quarterly Data

Book Value per Share CPI Adj_Book
201506 16.245 100.684 21.770
201509 15.693 100.392 21.091
201512 15.549 99.792 21.023
201603 15.242 100.470 20.469
201606 14.835 101.688 19.684
201609 14.075 101.861 18.644
201612 14.906 101.863 19.744
201703 14.327 102.862 18.793
201706 14.345 103.349 18.728
201709 14.887 104.136 19.289
201712 15.243 104.011 19.774
201803 15.814 105.290 20.265
201806 15.702 106.317 19.927
201809 17.014 106.507 21.554
201812 17.464 105.998 22.230
201903 20.597 107.251 25.912
201906 19.574 108.070 24.438
201909 19.960 108.329 24.861
201912 20.558 108.420 25.584
202003 21.107 108.902 26.151
202006 20.247 108.767 25.117
202009 20.761 109.815 25.508
202012 21.214 109.897 26.046
202103 21.587 111.754 26.063
202106 22.064 114.631 25.970
202109 21.483 115.734 25.046
202112 21.905 117.630 25.126
202203 22.313 121.301 24.819
202206 21.494 125.017 23.198
202209 22.182 125.227 23.900
202212 22.827 125.222 24.596
202303 23.864 127.348 25.284
202306 22.555 128.729 23.641
202309 23.572 129.860 24.492
202312 24.022 129.419 25.044
202403 22.665 131.776 23.207
202406 24.855 132.554 25.300
202409 25.959 133.029 26.329
202412 26.424 133.157 26.775
202503 24.159 134.927 24.159

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Scivision Biotech  (TPE:1786) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Scivision Biotech's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=96.20/23.24
=4.14

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Scivision Biotech was 6.02. The lowest was 2.02. And the median was 3.40.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Scivision Biotech Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Scivision Biotech's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Scivision Biotech Business Description

Traded in Other Exchanges
N/A
Address
No. 1, South 1st Road, KEPZ, Kaohsiung, TWN, 806
Scivision Biotech Inc is engaged in the manufacturing and distribution of hyaluronic acid medical supplies in Taiwan. It offers medical devices, including absorbable adhesion barriers, dermal implants, synovial fluid supplements, and intravesical instillation.

Scivision Biotech Headlines

No Headlines